Sign In
Buy SRPT
$14.86
-0.700 (-4.50%)
At Close: Jul 31, 2026
Sarepta Therapeutics to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference
04:30pm, Monday, 02'nd Nov 2020
CAMBRIDGE, Mass., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will pa
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07:16pm, Friday, 30'th Oct 2020
CAMBRIDGE, Mass., Oct. 30, 2020 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on October 30, 2020 that
Sarepta Therapeutics Clears Key Benchmark, Hitting 80-Plus RS Rating
02:25pm, Thursday, 29'th Oct 2020
A Relative Strength Rating upgrade for Sarepta Therapeutics shows improving technical performance. The post Sarepta Therapeutics Clears Key Benchmark, Hitting 80-Plus RS Rating appeared first on Inves
Sarepta Therapeutics to Announce Third Quarter 2020 Financial Results and Recent Corporate Developments on November 5, 2020
08:36am, Thursday, 29'th Oct 2020
CAMBRIDGE, Mass., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report third quarter 2020 financial resul
